SCHEMBL14033830

SCHEMBL14033830

Clc1ccc(C(Cl)c2cnc3ccccc3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 1/20 0.43
CNR1 P21554 2/20 0.43
CNR2 P34972 2/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
TMPRSS4 Q9NRS4 1/20 0.42
ALPL P05186 2/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
S1PR3 Q99500 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PDGFRB P09619 2/20 0.39
PDGFRA P16234 2/20 0.39
MGAM O43451 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033741 0.83 CHEK2 (0.49) NPC1RAB9ASMN1; SMN2CYP1A2CNR1
SCHEMBL8918196 0.81 NR4A2 (0.50) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL17541593 0.76 CYP1A2 (0.53) CYP1A2HPGDPDGFRBPDGFRAMGAM
SCHEMBL14033839 0.75 CYP2A6 (0.56) NPC1RAB9ACNR1MEN1KMT2A
SCHEMBL438735 0.73 CYP1A2 (0.57) NPC1RAB9ASMN1; SMN2CYP1A2MEN1
SCHEMBL29375315 0.73 PDGFRB (0.66) NPC1RAB9ASMN1; SMN2CYP1A2CNR1
SCHEMBL29060493 0.73 PDGFRB (0.66) NPC1RAB9ASMN1; SMN2CYP1A2CNR1
SCHEMBL2607479 0.72 CYP1A2 (0.57) CYP1A2CNR2HPGDPDGFRBPDGFRA
SCHEMBL30474837 0.72 CYP1A2 (0.52) RAB9ACYP1A2HPGDPDGFRBPDGFRA
SCHEMBL372349 0.72 CYP1A2 (0.52) RAB9ACYP1A2HPGDPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed